P2 Clinical evaluation of the next-generation sequencing (NGS) for detection of drug-resistance mutations in HIV-1

• G. Dessilly,
• L. Goeminne,
• A. Duquenne,
• A.T. Vandenbroucke,
• E. André,
• F.E. Dufrasne,
• A. Martin,
• B. Kabamba,
• J. Ruelle

Affiliations

G. Dessilly

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

L. Goeminne

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

A. Duquenne

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

A.T. Vandenbroucke

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

E. André

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

F.E. Dufrasne

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

A. Martin

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

B. Kabamba

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium

J. Ruelle

Université catholique de Louvain, AIDS Reference Laboratory, Institute of Experimental and Clinical Research (IREC), Medical Microbiology Unit (MBLG), Brussels, Belgium